Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: A prospective cohort study

Reproductive Toxicology

Volumn 27, Issue 2, 2009, Pages 196-198

  Lee, Si Won ^a   Han, Jung Yeol ^a   Choi, June Seek ^a   Chung, Jin Hoon ^a   Kim, Moon Young ^a   Yang, Jae Hyug ^a   Koong, Mi Kyoung ^a   Nava Ocampo, Alejandro A ^b,c,d   Koren, Gideon ^b  

^a Cheil General Hospital   (South Korea)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PharmaReasons   (Canada)

Author keywords

Aminoglycosides; Maternal exposure; Transplacental exposure

Indexed keywords

RIBOSTAMYCIN;

ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; COMMON COLD; CONJUNCTIVITIS; CONTROLLED STUDY; CYSTITIS; DERMATITIS; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LACERATION; MAJOR CLINICAL STUDY; OTITIS MEDIA; PREGNANCY OUTCOME; PROSPECTIVE STUDY; VAGINITIS;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTI-BACTERIAL AGENTS; BIRTH WEIGHT; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; RIBOSTAMYCIN; RISK ASSESSMENT;

EID: 62549104612     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.12.008     Document Type: Article

References (16)

1. Zhou S.L., Shen G., and Zhong H.F. Pharmacokinetics of ribostamycin in paediatric patients. Clin Pharmacokinet 22 (1992) 144-151
2. Kitasato I., Yokota M., Inouye S., and Igarashi M. Comparative ototoxicity of ribostamycin, dactimicin, dibekacin, kanamycin, amikacin, tobramycin, gentamicin, sisomicin and netilmicinin the inner ear of guinea pigs. Chemotherapy 36 (1990) 155-168
3. Dodson M.G. Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation. J Reprod Med 39 (1994) 285-296
4. Micromedex Healthcare Series: Thomson Micromedex, Greenwood Village, CO [accessed March 2008].
5. Conway M., and Birt B.D. Streptomycin in pregnancy: effect on the foetal ear. Br Med J 2 (1965) 260-263
6. Canadian Adverse Drug Reaction Monitoring Program. Summary of reported adverse reactions. Suspected drug: gentamicin-SOC: fetal disorders; all reports received from January 1, 1965 to June 30, 2008. Available at: http://www.hc-sc.gc.ca/dhp-mps/medeff/databasdon/index-eng.php [accessed August 4, 2008].
7. Sánchez S.-T.C., Gutiérrez F.R., Ibáñez R.C., and Moro S.M. Relationship between a case of severe hearing loss and use of gentamycin in the pregnant mother. An Esp Pediatr 49 (1998) 397-398 [in Spanish]
8. Kirkwood A., Harris C., Timar N., and Koren G. Is gentamicin ototoxic to the fetus?. J Obstet Gynaecol Can 29 (2007) 140-145
9. Czeizel A.E., Rockenbauer M., Olsen J., and Sorensen H.T. A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand J Infect Dis 32 (2000) 309-313
10. Di Nola F., Eandi M., and Soranzo M.L. Kinetic and clinical research into a new aminoglycosidic antibiotic: ribostamycin. Drugs Under Exp Clin Res 6 (1980) 77-90
11. Yamasaku F., Suzuki Y., and Umemura K. Pharmacokinetics of ribostamycin in healthy volunteers and patients with impaired renal function. Jpn J Antibiot 33 (1983) 1318-1331
12. Zhang M., and Gu Y. Studies on the clinical pharmacology of ribostamycin. New Drugs Clin Rem 4 (1985) 199-201
13. Murata S., Kadosawa H., Shomura T., and Umemura K. Studies on absorption, distribution, metabolism and excretion of drugs. Distribution, metabolism and excretion of ribostamycin. Yakuzaigaku 31 (1971) 1-7
14. Han J.Y., Nava-Ocampo A.A., and Koren G. Unintended pregnancies and exposure to potential human teratogens. Birth Defects Res A Clin Mol Teratol 73 (2005) 245-248
15. Guthrie O.W. Aminoglycoside induced ototoxicity. Toxicology 249 (2008) 91-96
16. Sadler T.W. Langman's medical embryology. 9th ed. (2004), Lippincott Williams and Wilkins, Baltimore p. 403-14